Information processing speed in ecstasy (MDMA) users

Human Psychopharmacology

Volumn 22, Issue 2, 2007, Pages 81-88

  Wareing, Michelle ^a   Fisk, John E ^b   Montgomery, Catharine ^a   Murphy, Philip N ^c   Chandler, Martin D ^a  

^a LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

^c EDGE HILL UNIVERSITY   (United Kingdom)

Author keywords

Ecstasy; Information processing speed; Working memory

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALCOHOL; AMPHETAMINE; CANNABIS; COCAINE;

ADULT; AGE DISTRIBUTION; ANALYSIS OF COVARIANCE; ANALYTICAL ERROR; ARTICLE; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG USE; HUMAN; MATHEMATICS; MEMORY DISORDER; MENTAL PERFORMANCE; PATTERN RECOGNITION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TIME; WORKING MEMORY;

ADULT; AMPHETAMINE; CANNABIS; COCAINE; ETHANOL; HUMANS; MEMORY; MENTAL PROCESSES; MULTIVARIATE ANALYSIS; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PATTERN RECOGNITION, VISUAL; PSYCHOMOTOR PERFORMANCE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SELF ADMINISTRATION; SUBSTANCE-RELATED DISORDERS; TIME FACTORS;

EID: 33947720408     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.827     Document Type: Article

References (29)

1. Arranz B, Eriksson A, Mellerup E, Plenge P, Marcusson J. 1993. Effect of aging in human cortical pre- and postsynaptic serotonin binding sites. Brain Res 620: 163-166.
2. Croft RJ, Mackay AJ, Mills ATD, Gruzelier JGH. 2001. The relative contributions of ecstasy and cannabis to cognitive impairment. Psychopharmacology 153: 373-379.
3. de Win MML, Reneman L, Reitsma JB, den Heeten GJ, Booij J, van den Brink W. 2004. Mood disorders and serotonin transporter density in ecstasy users - the influence of long-term abstention, dose, and gender. Psychopharmacology (E Published ahead of print - online).
4. Fischer C, Hatzidimitiou G, Wlos J, Katz J, Ricaurte GA. 1995. Reorganisation of ascending 5-HT axon projections in animals previously exposed to the recreational drug (+) 3, 4-methleneioxymethamphetamine (MDMA, "Ecstasy"). J Neurosci 15: 5476-5485.
5. Fisk JE, Montgomery C, Wareing M, Murphy P. 2005. Reasoning deficits in ecstasy (MDMA) users. Psychopharmacology 181: 550-559.
6. Fisk JE, Warr P. 1996. Age and working memory: the role of perceptual speed, the central executive, and the phonological loop. Psychol Aging 11: 316-323.
7. Fox HC, Parrott AC, Turner JJD. 2001. Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug. Psychopharmacology 15: 273-281.
8. Halpern JH, Pope HG, Sheerwood AR, Barry S, Hudson JI, Yurgelun-Todd D. 2004. Residual neuropsychological effects of illicit 3, 4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs. Drug Alcohol Depend 75: 135-147.
9. Harrison ER, Haaga J, Richards T. 1993. Self-reported drug use data: what do they reveal? Am J Drug Alcohol Abuse 19:423-441.
10. McCann UD, Szabo Z, Scheffel U, Dannals RF, Ricaurte GA. 1998. Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings. Lancet 352: 1433-1437.
11. McCann UD, Mertl M, Eligulashvili V, Ricaurte GA. 1999. Cognitive performance in (+)3, 4-ethleneioxymethamphetamine (MDMA, "ecstasy") users: a controlled study. Psychopharmacology 143: 417-425.
12. Meltzer CC, Smith G, DeKosky ST, et al. 1998. Serotonin in aging, late-life depression, and Alzheimer's disease: the emerging role of functional imagining. Neuropsychophamacology 18: 407-430.
13. Morgan MJ. 1998. Recreational uses of "Ecstasy" (MDMA) is associated with elevated impulsivity. Neuropsychophamacology 19: 252-264.
14. Morgan MJ, McFie L, Fleetwood LH, Robinson JA. 2002. Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence. Psychopharmacology 159: 294-303.
15. Reneman L, Booij J, Schmand B, van den Bink W, Gunning B. 2000. Memory disturbances in "Ecstasy" users are correlated with an altered brain serotonin neurotransmission. Psychopharmacology 148: 322-324.
16. Rypma B, D'Esposito M. 2000. Isolating the neural mechanisms of age-related changes in human working memory. Nat Neurosci 3: 509-515.
17. Salthouse TA. 1994. The aging of working memory. Neuropsychology 8: 535-543.
18. Salthouse TA. 1996. The processing speed theory of adult age differences in cognition. Psychol Rev 103: 403-428.
19. Salthouse TA. 2000. Aging and measures of processing speed. Biol Psychol 54: 35-54.
20. Salthouse TA, Babcock RL. 1991. Decomposing adult age differences in working memory. Dev Psychol 27: 763-776.
21. Salthouse TA, Coon VE. 1994. Interpretation of differential deficits: the case of aging and mental arithmetic. J Exp Psychol-Learn Mem Cogn 20: 1172-1182.
22. Tabachnick BG, Fidell LS. Using Multivarzate Statistics, 4th edn, Allyn & Bacon: Boston, 2001.
23. Van Dyck CH, Malison RT, Seibly JP, et al. 2000. Age-related decline in central serotonin transporter availability with [1231] β-CIT SPECT. Neurobiol Aging 21: 497-501.
24. Verkes RI, Gijsman J, Pieters MSM, et al. 2001. Cognitive performance and serotonergic function in users of ecstasy. Psychopharmacology 153: 196-202.
25. Wareing M, Fisk JE, Murphy PN. 2000. Working memory deficits in current and previous users of MDMA ('ecstasy'). Br J Psychol 91: 181-188.
26. Wareing M, Fisk JE, Murphy PN. 2004a. Verbal working memory deficits in current and previous users of MDMA. Human Psychopharmacol Clin Exp 19: 225-234.
27. Wareing M, Murphy PN, Fisk JE. 2004b. Visuospatial memory impairments in users of MDMA ('ecstasy'). Psychopharmacology, Special Issue: MDMA ('ecstasy') 173: 391-397.
28. Wareing M, Fisk JE, Murphy P, Montgomery C. 2005. Visuo-spatial working memory deficits in current and former users of MDMA ('Ecstasy'). Human Psychopharmacol Clin Exp 20: 115-123.
29. Zimprich D, Martin M. 2002. Can longitudinal changes in processing explain longitudinal age changes in fluid intelligence. Psychol Aging 17: 690-695.